1789
vs
T
Taiwan Weighted Index
1789
Over the past 12 months, ScinoPharm Taiwan Ltd has underperformed Taiwan Weighted Index, delivering a return of -19% compared to the Taiwan Weighted Index's +23% growth.
Stocks Performance
1789 vs Taiwan Weighted Index
Performance Gap
1789 vs Taiwan Weighted Index
Performance By Year
1789 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ScinoPharm Taiwan Ltd
Glance View
ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.